Axio BioPharma: Valuation, Funding & Investors
Axio BioPharma develops software for biomanufacturing collaboration and data interoperability. Its Axio Lattice platform connects process information across systems such as LIMS, MES, ELN, historians, ERP, and QMS without requiring companies to replace existing systems, move underlying data, or change data ownership.
Leadership & Board
- Current Number of Employees
- 8
- Current LinkedIn Followers
- 4,676
Latest Estimated Valuation
- Total Amount Raised
- $2M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $2M
- Latest Funding Round
- Pre-Seed
Company Momentum
PositiveAxio BioPharma LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Axio BioPharma had 8 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Axio BioPharma had 4,676 followers as of November 9, 2026. The number of followers increased by 21 (0.45%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 23, 2026 | Pre-Seed | $2.40M | ― |
Similar Companies
A snapshot of private companies similar to Axio BioPharma, helping you discover and navigate related company profiles.
Related News and Analysis
